TuHURA Biosciences (STU:PL3) Other Current Liabilities: €1.48 Mil (As of Mar. 2026)


STU:PL3 TuHURA Biosciences Inc STU:PL3
14 GF Score
Price €1.96
! 1 Warning Sign
View Full Analysis

What is TuHURA Biosciences Other Current Liabilities?

TuHURA Biosciences STU:PL3 +0.51% 14 Other Current Liabilities is €1.48 Mil as of Mar. 2026. GuruFocus rates STU:PL3 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

TuHURA Biosciences's other current liabilities for the quarter that ended in Mar. 2026 was €1.48 Mil.

TuHURA Biosciences's quarterly other current liabilities declined from Sep. 2025 (€3.40 Mil) to Dec. 2025 (€1.30 Mil) but then increased from Dec. 2025 (€1.30 Mil) to Mar. 2026 (€1.48 Mil).

TuHURA Biosciences's annual other current liabilities declined from Dec. 2023 (€1.42 Mil) to Dec. 2024 (€1.11 Mil) but then increased from Dec. 2024 (€1.11 Mil) to Dec. 2025 (€1.30 Mil).

TuHURA Biosciences Other Current Liabilities Related Terms

TuHURA Biosciences Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for TuHURA Biosciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TuHURA Biosciences Other Current Liabilities Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
0.40 0.64 1.42 1.11 1.30

TuHURA Biosciences Quarterly Data
Dec21 Mar22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 2.89 3.40 1.30 1.48
STU:PL3
14GF Score
TuHURA Biosciences Inc STU:PL3
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TuHURA Biosciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €1.48 Mil mean?
TuHURA Biosciences (STU:PL3) has a Other Current Liabilities of €1.48 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on TuHURA Biosciences.
Is TuHURA Biosciences' Other Current Liabilities too high?
TuHURA Biosciences' current Other Current Liabilities is €1.48 Mil. Overall, TuHURA Biosciences has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does TuHURA Biosciences' Other Current Liabilities compare to ACOG and MENS?
TuHURA Biosciences' Other Current Liabilities of €1.48 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on TuHURA Biosciences. TuHURA Biosciences's current Other Current Liabilities is €1.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TuHURA Biosciences stock overvalued right now?
TuHURA Biosciences (STU:PL3) has a current Other Current Liabilities of €1.48 Mil. The current Other Current Liabilities is €1.48 Mil. TuHURA Biosciences' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For TuHURA Biosciences (STU:PL3), the current Other Current Liabilities is €1.48 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TuHURA Biosciences Business Description

Other Exchanges HURA:USA
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
14GF Score

Get the complete analysis for STU:PL3

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.96
Price